2003 Seoul National University Hospital
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
JANG, INJIN
BDTX-1535-101, NCT05256290: Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

Recruiting
1/2
200
US
BDTX-1535 monotherapy
Black Diamond Therapeutics, Inc.
Non-Small Cell Lung Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Cancer, NSCLC, Advanced Lung Carcinoma, Epidermal Growth Factor Receptor C797S, Epidermal Growth Factor Receptor G719X, EGF-R Positive Non-Small Cell Lung Cancer, EGFR-TKI Resistant Mutation
07/25
06/26
NCT04827472: Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

Recruiting
1
36
RoW
Normal saline, DWJ1521, DWP14012 Tablet
Daewoong Pharmaceutical Co. LTD.
Healthy
06/21
07/21
NCT05085184: Study to Evaluate the Safety and PK of UI018

Active, not recruiting
1
44
RoW
administration of UI018, co-administration of UIC201806 and UIC201602
Korea United Pharm. Inc.
Hyperlipemia, Mixed
11/21
09/22
NCT06508645: Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers

Completed
1
33
RoW
DWP14012 injection, Fexuprazan
Daewoong Pharmaceutical Co. LTD.
Healthy Volunteers
03/22
04/22
NCT06263998: Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

Recruiting
1
60
RoW
NCP112, NCP112 Placebo
Huons Co., Ltd.
Xerophthalmia
11/25
01/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
JANG, INJIN
BDTX-1535-101, NCT05256290: Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

Recruiting
1/2
200
US
BDTX-1535 monotherapy
Black Diamond Therapeutics, Inc.
Non-Small Cell Lung Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Cancer, NSCLC, Advanced Lung Carcinoma, Epidermal Growth Factor Receptor C797S, Epidermal Growth Factor Receptor G719X, EGF-R Positive Non-Small Cell Lung Cancer, EGFR-TKI Resistant Mutation
07/25
06/26
NCT04827472: Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

Recruiting
1
36
RoW
Normal saline, DWJ1521, DWP14012 Tablet
Daewoong Pharmaceutical Co. LTD.
Healthy
06/21
07/21
NCT05085184: Study to Evaluate the Safety and PK of UI018

Active, not recruiting
1
44
RoW
administration of UI018, co-administration of UIC201806 and UIC201602
Korea United Pharm. Inc.
Hyperlipemia, Mixed
11/21
09/22
NCT06508645: Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers

Completed
1
33
RoW
DWP14012 injection, Fexuprazan
Daewoong Pharmaceutical Co. LTD.
Healthy Volunteers
03/22
04/22
NCT06263998: Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

Recruiting
1
60
RoW
NCP112, NCP112 Placebo
Huons Co., Ltd.
Xerophthalmia
11/25
01/26

Download Options